Search by Drug Name or NDC

NDC 42291-0064-30 Atomoxetine 10 mg/1 Details

Atomoxetine 10 mg/1

Atomoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is ATOMOXETINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.

Related Packages: 42291-0064-30
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Atomoxetine

Product Information

NDC	42291-0064
Product ID	42291-064_0e8b3994-a060-af6e-e063-6294a90a60ad
Associated GPIs	61354015100110
GCN Sequence Number	051489
GCN Sequence Number Description	atomoxetine HCl CAPSULE 10 MG ORAL
HIC3	H7Y
HIC3 Description	TX FOR ATTENTION DEFICIT-HYPERACT.(ADHD), NRI-TYPE
GCN	18776
HICL Sequence Number	024703
HICL Sequence Number Description	ATOMOXETINE HCL
Brand/Generic	Generic
Proprietary Name	Atomoxetine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Atomoxetine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	ATOMOXETINE HYDROCHLORIDE
Labeler Name	AvKARE
Pharmaceutical Class	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA079022
Listing Certified Through	2025-12-31

Package

NDC 42291-0064-30 (42291006430)

Pricing Information	N/A
NDC Package Code	42291-064-30
Billing NDC	42291006430
Package	30 CAPSULE in 1 BOTTLE (42291-064-30)
Marketing Start Date	2022-04-12
NDC Exclude Flag	N